Advertisement
News
Subscribe to MDT Magazine News

CVS Caremark Study Finds Medication Adherence Leads to Lower Health Care Costs, Even After Accounting for Increased Prescription Drug Spending

January 6, 2011 4:34 am | by Bio-Medicine.Org | Comments

WOONSOCKET, R.I., Jan. 6, 2011 /- A new CVS Caremark study analyzing annual pharmacy and medical costs over a three-year period for patients with one or more of four chronic diseases concludes that patients who take medications as doctors direct may save the health care system as much as...

TOPICS:

Esperion Therapeutics Initiates Phase 2 Clinical Study for ETC-1002

January 6, 2011 4:34 am | by Bio-Medicine.Org | Comments

PLYMOUTH, Mich., Jan. 6, 2011 /- Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that it has initiated a Phase 2 clinical study for ETC-1002, the company's...

TOPICS:

Amarin Prices Public Offering of American Depositary Shares

January 6, 2011 4:34 am | by Bio-Medicine.Org | Comments

MYSTIC, Conn. and DUBLIN, Jan. 6, 2011 /- Amarin Corporation plc (Nasdaq: AMRN ) (the "Company"), a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today announced the pricing of an underwritten public offering of 12,000,000 American Depositary Shares...

TOPICS:
Advertisement

The Center for Business Intelligence (CBI) Announces Virtual Conference on Imaging for Drug Development

January 6, 2011 4:33 am | by Bio-Medicine.Org | Comments

WOBURN, Mass., Jan. 6, 2011 /- The Center for Business Intelligence (CBI) is pleased to announce Preclinical and Clinical Imaging for Drug Development being held February 23, 2011 from 9:30 am - 6:00 pm EST. CBI provides a unique opportunity to bring together a diverse collection of...

TOPICS:

Former FDA Commissioner Joins Bexion Pharmaceuticals Board

January 6, 2011 4:32 am | by Bio-Medicine.Org | Comments

COVINGTON, Ky., Jan. 6, 2011 /- Bexion Pharmaceuticals, LLC announced today that it has added Lester Crawford, D.V.M., and Ph.D. to its Board of Directors. Dr. Crawford has had a distinguished career in the public and private sectors as well as academia. Over ten years of his career were...

TOPICS:

OnePartner selects MobileMD for Health Information Exchange

January 6, 2011 3:36 am | by Bio-Medicine.Org | Comments

DUFFIELD, Va. and WARMINSTER, Pa., Jan. 6, 2011 /- OnePartner, LLC selects MobileMD, Inc. for Health Information Exchange (HIE) component of innovative, cost effective, and rapidly deployed Electronic Health Record (EHR) solution. Leveraging popular cloud computing techniques designed...

TOPICS:

Echo Therapeutics Receives Funding and Commitment of Approximately $5.5 Million

January 6, 2011 3:36 am | by Bio-Medicine.Org | Comments

FRANKLIN, Mass., Jan. 6, 2011 /- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE ), a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude™ SkinPrep System for transdermal drug...

TOPICS:

Viveve Obtains CE Mark for Gynecologic Treatment of Vaginal Laxity

January 6, 2011 3:35 am | by Bio-Medicine.Org | Comments

PALO ALTO, Calif., Jan. 6, 2011 /- Viveve, Inc. , a development stage women's health company, announced today that it has received the European CE (Conformite Europeenne) mark for the use of its Viveve System for the non-surgical treatment of laxity of the vaginal introitus (opening),...

TOPICS:
Advertisement

Boston Scientific buys Intelect Medical for $60M

January 6, 2011 3:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Boston Scientific Corp. has acquired Intelect Medical Inc., a Boston-based company that recently moved here from Ohio, and is developing technologies for deep brain stimulation, for $60 million in cash.

TOPICS:

IRIDEX to Present at the OneMedForum San Francisco 2011 Conference

January 6, 2011 3:35 am | by Bio-Medicine.Org | Comments

MOUNTAIN VIEW, Calif., Jan. 6, 2011 /- IRIDEX Corporation (Nasdaq: IRIX ) today announced that management will present at the OneMedForum San Francisco 2011 Conference at 8:45 a.m. PST on Tuesday, January 11.  The conference will be held on January 11-13 at the Sir Francis Drake...

TOPICS:

CeNeRx Initiates Phase II Trial of TriRimaâ„¢ as Monotherapy in Treatment Resistant Depression

January 6, 2011 3:34 am | by Bio-Medicine.Org | Comments

RESEARCH TRIANGLE PARK, N.C., Jan. 6, 2011 /- CeNeRx BioPharma, Inc., today reported that it has initiated a Phase II trial of its new formulation of TriRima ™, the company's novel antidepressant in development as monotherapy for treatment resistant depression.  CeNeRx also...

TOPICS:

Vapotherm, Inc. Announces CE Mark Approval for Flowrest® Homecare Device

January 6, 2011 3:33 am | by Bio-Medicine.Org | Comments

STEVENSVILLE, Md., Jan. 6, 2011 /PRNewswire-USNewswire/ -- Vapotherm, the global leader in High Flow Therapy products, announced receiving CE marking for Flowrest®, a device designed for homecare and other low acuity environments. The Flowrest® device delivers warmed humidified...

TOPICS:

Sun Healthcare sets 2011 guidance

January 6, 2011 2:45 am | by The Associated Press | Comments

Health care facility operator Sun Healthcare Group Inc. said Thursday it expects earnings of between $1.30 and $1.45 per share in 2011, while expanding capacity.The company based in Irvine, Calif., also expects revenue between $1.95 billion and $2 billion.Analysts polled by Thomson Reuters expect...

Okla. inmate to be executed for 1995 murder

January 5, 2011 11:45 pm | by TIM TALLEY - Associated Press - Associated Press | Comments

An Oklahoma death row inmate convicted of the baseball-beating death of a convenience store work almost 16 years ago is scheduled to become the first person executed in the U.S. this year.Billy Don Alverson, 39, was convicted of first-degree murder and sentenced to die for the Feb, 26, 1995,...

Sinovac Provides Preliminary Unaudited Fourth Quarter 2010 Sales Range

January 5, 2011 11:34 pm | by Bio-Medicine.Org | Comments

BEIJING, Jan. 6, 2011 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA ), a leading provider of biopharmaceutical products in China, announced today its preliminary unaudited sales range for the fourth quarter and full year ended December 31, 2010. A conference call to discuss these...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading